Lipe & Dalton’s Exelon EXC Stock Holding History

Lipe & Dalton’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-202,031	Closed	-$4.45M	–	61
2013 Q2	$4.45M	Buy	+202,031	New	+$4.9M	3.69%	9

Other funds holding EXC

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lipe & Dalton's EXC Position: Q3 2013 in Review

Lipe & Dalton sold out of Exelon (EXC) in Q3 2013, closing a stake of 202,031 shares — an estimated $4.45M sold.

Lipe & Dalton first reported a position in EXC in Q2 2013 and held it in 1 quarter. The position peaked at $4.45M in Q2 2013. 634 funds tracked by Wall St. Rank hold EXC as of Q3 2013.

Lipe & Dalton reported no remaining Exelon position as of Q3 2013 after selling out during the quarter.
Lipe & Dalton sold 202,031 Exelon shares in Q3 2013, an estimated $4.45M.
Lipe & Dalton first reported a position in Exelon in Q2 2013 and held it in 1 quarter.
Lipe & Dalton's Exelon position peaked at $4.45M in Q2 2013.
634 funds tracked by Wall St. Rank held Exelon as of Q3 2013.

Based on Lipe & Dalton's 13F filing for Q3 2013, filed 30 Oct 2013.